Over the last three years, the proliferation of real-world data at scale has dramatically changed how researchers are thinking about study design, operations, and execution – and the role digital patient data can play. We believe that over the next five years, tokenized clinical trials will be critical to reducing study costs and a force multiplier for accelerating therapeutic innovations for patients. Read this blog post to learn more about about vision and investment in trial tokenization.